Fred Hutchinson Cancer Research Center Site Number : 840012

Seattle, Washington 98109

0 studies enrolling now · 1 studies all time

What they study most

Hematological Malignancy

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed